ArticleInfection & chemotherapy2024

Effectiveness and Tolerability of Dual Therapy with Dolutegravir Plus Darunavir/cobicistat in Treatment-Experienced Patients with HIV: A 144-Week Follow-Up.

Shin-Woo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.